Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc.（DBTX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · DBTX · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Decibel Therapeutics, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
DBTX 季度内部人买卖趋势
DBTX 内幕交易卖出 · DBTX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
DBTX 高管卖出股份 · DBTX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Sep 25, 2023 | Trask Anna CPO | Other | 106,864 | $374K | Form 4 |
| Sep 25, 2023 | Carson William H. Director | Other | 5,000 | $18K | Form 4 |
| Sep 25, 2023 | Lee John Jui-Jen Chief Development Officer | Other | 147,144 | $515K | Form 4 |
| Sep 25, 2023 | FINGER ALISON CECILY Director | Other | 5,000 | $18K | Form 4 |
| Sep 25, 2023 | MCLAUGHLIN KEVIN F Director | Other | 5,000 | $18K | Form 4 |
| Sep 25, 2023 | Reid Laurence See Remarks · Director | Other | 220,849 | $773K | Form 4 |
| Sep 25, 2023 | Kapusta Matthew C Director | Other | 10,000 | $35K | Form 4 |
| Sep 25, 2023 | Nochur Sara Director | Other | 5,000 | $18K | Form 4 |
| Jun 13, 2023 | Nochur Sara Director | Award | 5,000 | — | Form 4 |
| Jun 13, 2023 | Carson William H. Director | Award | 5,000 | — | Form 4 |
| Jun 13, 2023 | FINGER ALISON CECILY Director | Award | 5,000 | — | Form 4 |
| Jun 13, 2023 | MCLAUGHLIN KEVIN F Director | Award | 5,000 | — | Form 4 |
| Mar 19, 2023 | Kapusta Matthew C Director | Award | 10,000 | — | Form 4 |
| Mar 16, 2023 | Reid Laurence See Remarks · Director | Award | 195,000 | — | Form 4 |
| Jan 26, 2023 | Trask Anna CPO | Award | 105,000 | — | Form 4 |
| Jan 26, 2023 | Lee John Jui-Jen Chief Development Officer | Award | 120,000 | — | Form 4 |
| Jan 3, 2022 | Trask Anna See Remarks | Sale | 1 | $5 | Form 4 |
| Jan 3, 2022 | Trask Anna See Remarks | Sale | 377 | $2K | Form 4 |
| Dec 2, 2021 | Trask Anna See Remarks | Sale | 4,913 | $31K | Form 4 |
| Dec 2, 2021 | Trask Anna See Remarks | Sale | 378 | $2K | Form 4 |
| Nov 3, 2021 | Trask Anna See Remarks | Sale | 378 | $3K | Form 4 |
| Nov 2, 2021 | Trask Anna SEE REMARKS | Sale | 4,913 | $41K | Form 4 |
| Oct 14, 2021 | Trask Anna See Remarks | Sale | 5,364 | $40K | Form 4 |
| Sep 15, 2021 | Reid Laurence President and Chief Executive · Director | Purchase | 10,000 | $76K | Form 4 |
| Feb 17, 2021 | Schroder Adveq Technology IX S.C.S. 10 percent owner | Other | 524,328 | $524 | Form 4 |
Lee John Jui-Jen
Chief Development Officer
日期
Sep 25
股数
147,144
均价
$3.50
总金额
$515K
Reid Laurence
President and Chief Executive · Director
日期
Sep 15
股数
10,000
均价
$7.64
总金额
$76K
Schroder Adveq Technology IX S.C.S.
10 percent owner
日期
Feb 17
股数
524,328
均价
$0.00
总金额
$524
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 DBTX 内幕交易
DBTX 内幕交易
Decibel Therapeutics, Inc.（DBTX）内幕交易数据来源于公司内部人（包括DBTX）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。DBTX内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Decibel Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
DBTX 内幕交易 · 5个问题Decibel Therapeutics, Inc.（DBTX）的内部人包括高管和董事，如DBTX等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026